TEAS for Postoperative Nausea and Vomiting
What You Need to Know Before You Apply
What is the purpose of this trial?
The proposed research will utilize electroacupuncture, a type of needleless acupuncture that uses electrostimulation, in a randomized, double blind study, to evaluate the incidence of post-operative nausea and vomiting (PONV) in patients undergoing spinal surgeries with the transcutaneous electrical acupoint stimulation (TEAS) compared to patients without TEAS.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot use anti-nausea or nausea-inducing drugs within 3 days before surgery.
Is transcutaneous electrical acupoint stimulation (TEAS) safe for humans?
How does the treatment TEAS for postoperative nausea and vomiting differ from other treatments?
TEAS (Transcutaneous Electrical Acupoint Stimulation) is unique because it uses electrical stimulation on specific acupoints on the skin to help manage nausea and vomiting after surgery, unlike traditional medications that are taken orally or intravenously. This method is non-invasive and may offer an alternative for patients who prefer not to use drugs or have difficulty with medication side effects.678910
What data supports the effectiveness of the treatment TEAS for postoperative nausea and vomiting?
Who Is on the Research Team?
Sergio Bergese, MD
Principal Investigator
Ohio State University
Are You a Good Fit for This Trial?
This trial is for men and women over 18, with an ASA classification I-III, undergoing elective spinal surgery lasting no more than four hours. Participants must be able to consent. Excluded are those with certain medical conditions like vestibular disease, recent nausea or drug use, poorly controlled diabetes, metal/electrical implants, skin issues at the stimulation site, major psychiatric conditions, recent chemo/radiation therapy or investigational product use.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo spinal surgery with or without TEAS, with monitoring of PONV and opioid consumption
Immediate Post-operative Monitoring
Participants are monitored for PONV, opioid consumption, and adverse events for 24 hours post-surgery
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- TEAS
Find a Clinic Near You
Who Is Running the Clinical Trial?
Jyoti Pandya
Lead Sponsor